Story
Bachem Stock Surges on Plans for CHF 500 Million Swiss Production Facility
Summary
Shares in Swiss drug ingredient manufacturer Bachem jumped after the company announced a major investment of over CHF 500 million to build a new production facility. The project is designed to significantly boost its manufacturing capacity for peptides and oligonucleotides.
Shares of Bachem (SIX:BANB) surged on Tuesday after the Swiss drug ingredient manufacturer announced an investment of more than CHF 500 million to construct a new production facility in Switzerland. The plan represents one of the most significant single capital commitments in the company's history and is aimed at expanding its manufacturing capabilities for key pharmaceutical components.
A Major Capacity Expansion
The company stated the new large-scale greenfield facility will be built in the Sisslerfeld area of Canton Aargau. The primary goal of the investment is to decisively increase manufacturing capacity for peptide and oligonucleotide active pharmaceutical ingredients (APIs), which are complex molecules used in a growing class of modern therapeutic drugs.
This new project substantially exceeds Bachem's previously announced capital expenditure program for 2026, which was set at CHF 100 million. The fivefold increase in planned investment signals a major acceleration of the company's growth and production strategy.
Market Reaction and Context
AdInvestors reacted positively to the announcement, sending Bachem's stock up 7.9% to CHF 75.8 during Tuesday trading. The shares reached an intraday high of CHF 79.2, marking a strong recovery from the stock's 52-week low of CHF 48.52.
The expansion plan is supported by a solid financial foundation. For the 2025 fiscal year, Bachem reported:
- Revenues of CHF 604.8 million
- Recurring EBITDA of CHF 136.0 million
According to Investing.com, the move reinforces a bullish consensus among analysts, with firms including UBS, RBC Capital, and Berenberg Bank holding Buy ratings on the stock ahead of the news. Market participants will look for further details when Bachem releases its next earnings report, scheduled for July 30, 2026.
Read next
More on Stocks
Wells Fargo Options Volume Surges on 4% Drop, Revealing Split Market View
Heavy options trading in Wells Fargo followed a sharp intraday stock decline, with a near-even split between bullish and bearish contracts signaling significant disagreement among investors on the bank's near-term direction.
OMX Stockholm 30 Hits All-Time High, Led by Industrial Sector Rally
Sweden's benchmark stock index, the OMX Stockholm 30, closed at a new record on Tuesday, gaining 0.87% on the back of strong performance from industrial and basic materials companies.
Finnish Stocks Reach All-Time High, Led by Industrial and Tech Gains
Finland's benchmark OMX Helsinki 25 index gained 0.87% to close at a new record high on Tuesday, driven by strong performance in the industrial, technology, and basic materials sectors.
CAC 40 Edges Up 0.20% as Tech Gains Counteract Broader Weakness
France's CAC 40 index closed slightly higher on Tuesday, buoyed by strong performance in the technology sector, though losses in major financial and telecom stocks pointed to a mixed session for investors.